共 50 条
Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors
被引:11
|作者:
Lin, Han
[1
,2
,4
]
Hu, Guo-Xin
[1
,2
,3
]
Guo, Jingjing
[1
,2
]
Ge, Yufei
[4
,5
]
Liang, Guang
[3
]
Lian, Qing-Quan
[1
,2
]
Chu, Yanhui
Yuan, Xiaohuan
Huang, Ping
[6
]
Ge, Ren-Shan
[1
,2
]
机构:
[1] Wenzhou Med Coll, Affiliated Hosp 2, Wenzhou 325000, Peoples R China
[2] Wenzhou Med Coll, Inst Reprod Biomed, Wenzhou 325000, Peoples R China
[3] Wenzhou Med Coll, Sch Pharm, Wenzhou 325000, Peoples R China
[4] Populat Council, New York, NY 10065 USA
[5] Rockefeller Univ, New York, NY 10065 USA
[6] Tongde Hosp Zhejiang Prov, Dept Pharm, Hangzhou 310007, Zhejiang, Peoples R China
关键词:
11;
beta-HSD1;
beta-HSD2;
Mono-carbonyl curcumin analogues;
Inhibitors;
RAT LEYDIG-CELLS;
BETA-HYDROXYSTEROID DEHYDROGENASE;
IN-VITRO;
TYPE-1;
OBESITY;
VIVO;
D O I:
10.1016/j.bmcl.2013.05.080
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
A series of structurally novel mono-carbonyl curcumin analogues have been synthesized and biologically evaluated to test their inhibitory potencies and the structure-activity relationship (SAR) on human and rat 11 beta-hydroxysteroid dehydrogenase isoform (11 beta-HSD1) activities. 11 beta-HSD1 selective inhibitors have been discovered and compound A10 is discovered as a very potent with an IC50 value of 97 nM without inhibiting 11 beta-HSD2. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4362 / 4366
页数:5
相关论文